All recalls8,521 total
Failed Impurities/Degradation Specifications; during routine stability testing for impurities.
Undeclared allergen labeling (milk)
Undeclared allergen labeling (milk)
Undeclared allergen labeling (milk)
The hermetic seal on the lid of the cans may be compromised
Undeclared allergen labeling (milk)
Undeclared eggs and yellow #5.
Contains undeclared soy lecithin
Undeclared allergen labeling (milk)
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
potential for pieces of metal in product
potential for pieces of metal in product
potential for pieces of metal in product
potential for pieces of metal in product
Products contain undeclared allergens (milk, soy, and wheat) and undeclared sulfites, yellow 5, yellow 6.
Potential for contamination of Listeria monocytogenes. Environmental sample collected by FDA yielded positive results for one Zone 1 (cutting board) and one Zone 3 (floor drain).
Pieces of plastic in product
Salsa had pH of 4.7.
potential for pieces of metal in product
Pieces of plastic in product
Products contain undeclared allergens (milk, soy, peanut, and wheat) and undeclared sulfites, yellow 5, yellow 6, and red 40)
Elevated lead > 2ppm
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
Product may be contaminated with mold.
The firm received complaints of a "rancid taste" from consumers.
Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).
Product contains undeclared soy lecithin.
Labeling: Missing Label
potential to be contaminated with Listeria monocytogenes
potential to be contaminated with Listeria monocytogenes
Product contains undeclared hydrolyzed soy protein.
Undeclared allergen - egg
potential to be contaminated with Listeria monocytogenes
Failed Tablet/Capsule Specifications
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Product contains undeclared sulfites. The product was sampled by the NYSAGM s Food Safety Division and tested positive at 120.7 PPM Sulfites.